STRIPES Study: Study To Reduce Infection Post cEsarean Section
Primary Purpose
Chlorhexidine Gluconate Cloths, Infection; Cesarean Section, Infectious Morbidity
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
2% chlorhexidine gluconate (CHG) cloth
Placebo cloth
Sponsored by
About this trial
This is an interventional prevention trial for Chlorhexidine Gluconate Cloths focused on measuring cesarean section, chlorhexidine gluconate, CHG, surgical site infection, obstetrics, infection prevention, pregnancy
Eligibility Criteria
Inclusion Criteria:
- women
- > 24 weeks gestation
- scheduled for a primary or repeat cesarean section
Exclusion criteria:
- allergy to chlorhexidine
- unplanned or emergency cesarean section
Sites / Locations
- Icahn School of Medicine at Mount Sinai
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
CHG cloth
Placebo cloth
Arm Description
2% chlorhexidine gluconate (CHG) cloth
A fragrance free cleansing cloth
Outcomes
Primary Outcome Measures
Number of Participants With Incisional SSI
Number of participants with Incisional Surgical Site Infection (SSI)
Number of Adherent Participants With Incisional SSI
Among those with full adherence to the protocol and who were available for assessment at 6 weeks. Adherence to the protocol was assessed in the following 2 ways: evaluation of returned packages on the day of surgery and report ascertained by phone interview at 2 weeks.
Number of Participants With Endometritis
Number of participants with endometritis
Secondary Outcome Measures
Number of Participants With Maternal Complications
Number of participants with maternal complications
Incidence of Neonatal ICU Admissions
Maternal Length of Stay
Length of stay (index hospitalization)
Number of Participants With Maternal Readmissions
Number of participants with hospital readmission for wound complication
Full Information
NCT ID
NCT02402907
First Posted
March 25, 2015
Last Updated
October 16, 2020
Sponsor
Icahn School of Medicine at Mount Sinai
1. Study Identification
Unique Protocol Identification Number
NCT02402907
Brief Title
STRIPES Study: Study To Reduce Infection Post cEsarean Section
Official Title
A Randomized Trial to Determine if a Pre-operative Wash With a Chlorhexidine Cloth Reduces Infectious Morbidity in Patients Undergoing Cesarean Section
Study Type
Interventional
2. Study Status
Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
April 2015 (undefined)
Primary Completion Date
October 11, 2019 (Actual)
Study Completion Date
October 11, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Icahn School of Medicine at Mount Sinai
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The objective of this study is to determine if the use of chlorhexidine gluconate cloths prior to cesarean section reduce the rate of infectious morbidity (i.e. surgical site infections, endometritis).
The study will be offered to women who present for a scheduled primary or repeat cesarean section at Mount Sinai Medical Center. The eligible women will be randomized to use of a 2% chlorhexidine gluconate (CHG) cloth or placebo cloth (a fragrance free cleansing cloth) the night before and the morning of their scheduled procedure. Participants will be blinded to the arm in which they have been assigned. This study intends to show that the use of 2% CHG cloths prior to cesarean section will reduce the rate of surgical site infections.
Detailed Description
Chlorhexidine is a sterile, germ-free solution, which is regularly used to clean the skin immediately before surgery and works by killing or preventing the growth or spread of bacteria. Data exists in both the orthopedic and cardiac literature to show that an additional preoperative use of chlorhexidine further reduces the risk of post procedure infections. Limited data exists regarding the use of a preoperative use of chlorhexidine in patients undergoing Obstetric or Gynecologic procedures and there is no wash or cloth used prior to cesarean section as a standard of care. The hope for this study is to identify if an additional preoperative chlorhexidine wash will further decrease or prevent infection in women who deliver their babies via cesarean section.
All patients with a scheduled cesarean section surgery will be approached for enrollment during their pre-admission testing visit on the labor floor 2 days before the scheduled cesarean section, a visit that is standard procedure for this surgery. Once a patient is consented, she will be randomly assigned to one of the 2 arms of the study: the eligible women will be randomized to use of 2% chlorhexidine gluconate (CHG) cloths or placebo cloths (a fragrance free cleansing cloths) on the body the night before and the morning of their scheduled procedure. Participants will be blinded to the arm in which they have been assigned.
The purpose of this study is to determine if the use of 2% chlorhexidine gluconate cloths prior to cesarean section reduces the rate of surgical site wound infection and/or postpartum endometritis, which is an infection or inflammation of the endometrium (the inner lining of the uterus).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chlorhexidine Gluconate Cloths, Infection; Cesarean Section, Infectious Morbidity, Surgical Site Infections, Endometritis
Keywords
cesarean section, chlorhexidine gluconate, CHG, surgical site infection, obstetrics, infection prevention, pregnancy
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
1356 (Actual)
8. Arms, Groups, and Interventions
Arm Title
CHG cloth
Arm Type
Experimental
Arm Description
2% chlorhexidine gluconate (CHG) cloth
Arm Title
Placebo cloth
Arm Type
Placebo Comparator
Arm Description
A fragrance free cleansing cloth
Intervention Type
Device
Intervention Name(s)
2% chlorhexidine gluconate (CHG) cloth
Other Intervention Name(s)
CHG
Intervention Description
administration of a 2% CHG cloth at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.
Intervention Type
Device
Intervention Name(s)
Placebo cloth
Other Intervention Name(s)
Cleansing cloth
Intervention Description
administration of a cloth with the placebo (commercial cleansing cloth) at home on the night before and approximately 3 hours prior to cesarean delivery on the morning of the surgery.
Primary Outcome Measure Information:
Title
Number of Participants With Incisional SSI
Description
Number of participants with Incisional Surgical Site Infection (SSI)
Time Frame
at 6 weeks
Title
Number of Adherent Participants With Incisional SSI
Description
Among those with full adherence to the protocol and who were available for assessment at 6 weeks. Adherence to the protocol was assessed in the following 2 ways: evaluation of returned packages on the day of surgery and report ascertained by phone interview at 2 weeks.
Time Frame
at 6 weeks
Title
Number of Participants With Endometritis
Description
Number of participants with endometritis
Time Frame
at 6 weeks
Secondary Outcome Measure Information:
Title
Number of Participants With Maternal Complications
Description
Number of participants with maternal complications
Time Frame
up to 6 weeks
Title
Incidence of Neonatal ICU Admissions
Time Frame
up to 6 weeks
Title
Maternal Length of Stay
Description
Length of stay (index hospitalization)
Time Frame
at 6 weeks
Title
Number of Participants With Maternal Readmissions
Description
Number of participants with hospital readmission for wound complication
Time Frame
up to 6 weeks
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
women
> 24 weeks gestation
scheduled for a primary or repeat cesarean section
Exclusion criteria:
allergy to chlorhexidine
unplanned or emergency cesarean section
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Joanne Stone, MD
Organizational Affiliation
Icahn School of Medicine at Mount Sinai
Official's Role
Principal Investigator
Facility Information:
Facility Name
Icahn School of Medicine at Mount Sinai
City
New York
State/Province
New York
ZIP/Postal Code
10029
Country
United States
12. IPD Sharing Statement
Learn more about this trial
STRIPES Study: Study To Reduce Infection Post cEsarean Section
We'll reach out to this number within 24 hrs